References in bold are published by MATHEC members
References in italics are to mesenchymal stromal cells
2020
Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in refractory Takayasu arteritis: a retrospective multicenter case-series from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Laurent C, Marjanovic Z, Ricard L, Henes J, Dulery R, Badoglio M, Farge D, Snowden JA, Moraes D, Dias J, Mohty M, Soussan M, Fain O, Arnold R, Alexander T, Oliveira M-C, Mekinian A
Bone Marrow Transplant. 2020 Nov;55(11):2109-2113. doi: 10.1038/s41409-020-0907-4.
2018
Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis
Silva JMF, Ladomenou F, Carpenter B, Chandra S, Sedlacek P, Formankova R, Grandage V, Friswell M, Cant AJ, Nademi Z, Slatter MA, Gennery AR, Hambleton S, Flood TJ, Lucchini G, Chiesa R, Rao K, Amrolia PJ, Brogan P, Wedderburn LR, Glanville JM, Hough R, Marsh R, Abinun M, Veys P.
Blood Adv. 2018 Apr 10;2(7):777-786.
2016
Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis Network.
Vallet H, Seve P, Biard L, Baptiste Fraison J, Bielefeld P, Perard L, Bienvenu B, Abad S, Rigolet A, Deroux A, Sene D, Perlat A, Marie I, Feurer E, Hachulla E, Fain O, Clavel G, Riviere S, Bouche PA, Gueudry J, Pugnet G, Le Hoang P, Resche Rigon M, Cacoub P, Bodaghi B, Saadoun D; French Uveitis Network.
Arthritis Rheumatol. 2016 Jun;68(6):1522-30. doi: 10.1002/art.39667.
Rituximab versus azathioprine for ANCA-associated vasculitis maintenance therapy: impact on global disability and health-related quality of life.
Pugnet G, Pagnoux C, Terrier B, Perrodeau E, Puéchal X, Karras A, Khouatra C, Aumaître O, Cohen P, Maurier F, Decaux O, Ninet J, Gobert P, Quemeneur T, Blanchard-Delaunay C, Godmer P, Carron PL, Hatron PY, Limal N, Hamidou M, Ducret M, Daugas E, Papo T, Bonnotte B, Mahr A, Ravaud P, Mouthon L, Guillevin L; French Vasculitis Study Group.
Clin Exp Rheumatol. 2016 May-Jun;34(3 Suppl 97):S54-9.
2014
Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener’s). Results of a single-center cohort study on 66 patients.
Calich AL, Puéchal X, Pugnet G, London J, Terrier B, Charles P, Mouthon L, Guillevin L; French Vasculitis Study Group.
J Autoimmun. 2014 May;50:135-41. doi: 10.1016/j.jaut.2014.03.002.
Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients.
Charles P1, Néel A, Tieulié N, Hot A, Pugnet G, Decaux O, Marie I, Khellaf M, Kahn JE, Karras A, Ziza JM, Deligny C, Tchérakian C, Guillevin L; French Vasculitis Study Group.
Rheumatology (Oxford). 2014 Mar;53(3):532-9. doi: 10.1093/rheumatology/ket381.
2013
Biologics in relapsing polychondritis: a case series.
Moulis G, Sailler L, Pugnet G, Astudillo L, Arlet P.
Clin Exp Rheumatol. 2013 Nov-Dec;31(6):937-9.
Abatacept in relapsing polychondritis.
Moulis G, Pugnet G, Sailler L, Astudillo L, Arlet P.
Ann Rheum Dis. 2013 Nov;72(11):e27. doi: 10.1136/annrheumdis-2013-204336.
Rituximab: Recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitides.
Charles P, Bienvenu B, Bonnotte B, Gobert P, Godmer P, Hachulla É, Hamidou M, Harlé JR, Karras A, Lega JC, Le Quellec A, Mahr AD, Mouthon L, Papo T, Puéchal X, Pugnet G, Samson M, Sibilia J, Terrier B, Vandergheynst F, Guillevin L; French Vasculitis Study Group.
Presse Med. 2013 Oct;42(10):1317-30. doi: 10.1016/j.lpm.2013.08.003.
Cognitive Dysfunction and Dementia in Primary Sjögren’s Syndrome.
Blanc F, Longato N, Jung B, Kleitz C, Di Bitonto L, Cretin B, Collongues N, Sordet C, Fleury M, Poindron V, Gottenberg JE, Anne O, Lipsker D, Martin T, Sibilia J, de Seze J.
ISRN Neurol. 2013 Sep 19;2013:501327. doi: 10.1155/2013/501327.
Immunological and autoimmune considerations of Autism Spectrum Disorders.
Gesundheit B, Rosenzweig JP, Naor D, Lerer B, Zachor DA, Procházka V, Melamed M, Kristt DA, Steinberg A, Shulman C, Hwang P, Koren G, Walfisch A, Passweg JR, Snowden JA, Tamouza R, Leboyer M, Farge-Bancel D, Ashwood P.
J Autoimmun. 2013 Aug;44:1-7
Recovery of adrenal function after long-term glucocorticoid therapy for giant cell arteritis: a cohort study.
Jamilloux Y, Liozon E, Pugnet G, Nadalon S, Heang Ly K, Dumonteil S, Gondran G, Fauchais AL, Vidal E.
PLoS One. 2013 Jul 24;8(7):e68713. doi: 10.1371/journal.pone.0068713.
Long-term outcomes of hematopoietic stem cell transplantation for severe treatment-resistant autoimmune cytopenia in children.
Rabusin M, Snowden JA, Veys P, Quartier P, Dalle JH, Dhooge C, Di Bartolomeo P, Gonzalez-Vicent M, Gibson B, Iriondo A, Juergens H, Lisukov I, Messina C, Mialou V, Steward CG, Urban C, Renard M, Giurici N, Peters C, Badoglio M, Ronfani L, Dini G, Farge D, Saccardi R; European Group for Blood and Marrow Transplantation Autoimmune Diseases and Paediatric Disease Working Parties.
Biol Blood Marrow Transplant. 2013 Apr;19(4):666-9. doi: 10.1016/j.bbmt.2012.12.008.
2011
Giant cell arteritis as a cause of acute myocarditis in the elderly.
Pugnet G, Pathak A, Dumonteil N, Sailler L.
J Rheumatol. 2011 Nov;38(11):2497. doi: 10.3899/jrheum.110609.
2009
Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
Vija L, Farge D, Gautier JF, Vexiau P, Dumitrache C, Bourgarit A, Verrecchia F, Larghero J.
Diabetes Metab. 2009 Apr;35(2):85-93. doi: 10.1016/j.diabet.2008.10.003.
The antiphospholipid syndrome.
Pasquali JL, Poindron V, Korganow AS, Martin T.
Best Pract Res Clin Rheumatol. 2008 Oct;22(5):831-45. doi: 10.1016/j.berh.2008.08.008.
2007
Haematopoietic stem cell transplantation for vasculitis including Behcet’s disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature.
Daikeler T, Kötter I, Bocelli Tyndall C, Apperley J, Attarbaschi A, Guardiola P, Gratwohl A, Jantunen E, Marmont A, Porretto F, Musso M, Maurer B, Rinaldi N, Saccardi R, Tyndall A; EBMT Autoimmune Diseases Working Party.
Ann Rheum Dis. 2007 Feb;66(2):202-7.
Pathogenesis of the antiphospholipid syndrome.
Pasquali JL, Poindron V, Korganow AS, Martin T.
Presse Med. 2007 Apr;36(4 Pt 2):667-73.
2000
Salivary gland lymphomas in patients with Sjögren’s syndrome may frequently develop from rheumatoid factor B cells
Martin T, Weber JC, Levallois H, Labouret N, Soley A, Koenig S, Korganow AS, Pasquali JL.
Arthritis Rheum. 2000 Apr;43(4):908-16.
1994
Infiltrating T cells from patients with primary Sjögren’s syndrome express restricted or unrestricted T cell receptor V beta regions depending on the stage of the disease.
Legras F, Martin T, Knapp AM, Pasquali JL.
Eur J Immunol. 1994 Jan;24(1):181-5.
1993
Lacrimal and salivary lymphoma in primary Sjögren’s syndrome.
Weber JC, Martin T, Blaison G, Labouret N, Sahel J, Storck D, Pasquali JL.
Ann Med Interne (Paris). 1993;144(8):567.